Who is sponsoring NCT03317769?

NCT03317769 is sponsored by Posit Science Corporation.

What drugs are being tested in NCT03317769?

Interventions in NCT03317769: Computerized Plasticity-Based Adaptive Cognitive Training, Commercially available computerized training, Optimized social skills training, Unstructured support group sessions.

What condition does NCT03317769 study?

NCT03317769 studies Schizophrenia.

Is NCT03317769 still recruiting?

NCT03317769 is currently completed. Last updated 23 July 2019.

Last reviewed 2019-07-23 · How we verify

NCT03317769: CLIMB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Creating Live Interactions to Mitigate Barriers

Completed NA Last updated 23 July 2019

What this trial tests

NA trial testing Computerized Plasticity-Based Adaptive Cognitive Training in Schizophrenia in 31 participants. Completed in 6 June 2019.

Timeline

1 April 2018

Primary endpoint
31 May 2019

6 June 2019

Quick facts

Lead sponsor	Posit Science Corporation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	31
Start date	1 April 2018
Primary completion	31 May 2019
Estimated completion	6 June 2019
Sites	1 location across United States

Drugs / interventions tested

Computerized Plasticity-Based Adaptive Cognitive Training
Commercially available computerized training
Optimized social skills training
Unstructured support group sessions

Conditions studied

Schizophrenia — all drugs for Schizophrenia →

Sponsor

Posit Science Corporation — full company profile →

Who can join

Adults 18 to 60, any sex, with Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a validation study to evaluate the acceptability, feasibility and impact of a mobile psychosocial intervention to enhance social functioning in people with schizophrenia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improving social functioning in people with schizophrenia-spectrum disorders via mobile experimental interventions: Results from the CLIMB pilot trial.
Dabit S, Quraishi S, Jordan J, Biagianti B. · · 2021 · cited 11× · PMID 34381699 · DOI 10.1016/j.scog.2021.100211

Verify or expand the search:

Other trials of Computerized Plasticity-Based Adaptive Cognitive Training

Trials testing the same drug.

NCT06589024 — Remote STATE Training for Insomnia in Older Adults · NA · active not recruiting
NCT05599490 — Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB · NA · completed
NCT05022589 — Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk · NA · completed
NCT04149457 — Improving Neurological Health in Aging Via Neuroplasticity-based Computerized Exercise · NA · completed
NCT03604380 — STATE Trial: SusTained Attention Training to Enhance Sleep - Remote · NA · completed

Other recruiting trials for Schizophrenia

Currently open trials in the same condition.

NCT07424404 — A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au · Phase 3 · recruiting
NCT07467993 — Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia · Phase 2 · recruiting
NCT07379827 — Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · recruiting
NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting

Other Posit Science Corporation trials

Trials by the same sponsor.

NCT07243600 — Improving Neurological Health With Acetylcholine Via Neuroplasticity-based Computerized Exercise in Mild Cognitive Impai · NA · not yet recruiting
NCT06589024 — Remote STATE Training for Insomnia in Older Adults · NA · active not recruiting
NCT05599490 — Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB · NA · completed
NCT05529706 — Community-based Brain Health Program to Address Dementia Risk · NA · completed
NCT05022589 — Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03317769 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Posit Science Corporation
Last refreshed: 23 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03317769.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing